WaferGen Bio-Systems (WGBS) Misses Q2 EPS by 8c; Trims FY16 Revenue Outlook

August 9, 2016 4:04 PM EDT
Get Alerts WGBS Hot Sheet
Trade WGBS Now!
Join SI Premium – FREE

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

WaferGen Bio-Systems (NASDAQ: WGBS) reported Q2 EPS of ($0.26), $0.08 worse than the analyst estimate of ($0.18). Revenue for the quarter came in at $2.5 million versus the consensus estimate of $2.6 million.

At June 30, 2016, WaferGen had cash and cash equivalents of approximately $7.4 million.


WaferGen Bio-Systems sees FY2016 revenue of $10-12 million, versus prior guidance of $12-13 million.

For earnings history and earnings-related data on WaferGen Bio-Systems (WGBS) click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Earnings, Guidance

Related Entities


Add Your Comment